ArticleBMC surgery2025
Trends of copper deficiency following one anastomosis gastric bypass and Roux-en-Y gastric bypass.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Follow-up Strategies in Metabolic and Bariatric Surgery: Current strategies and Challenges.Journal of metabolic and bariatric surgery · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCopper deficiency is an under-recognized complication after metabolic and bariatric surgery (MBS) with hematologic and neurologic sequelae. Comparative evidence between one-anastomosis gastric bypass (OAGB) and Roux-en-Y gastric bypass (RYGB) is limited. We compared time-dependent copper trends and deficiency prevalence after OAGB versus RYGB and identified associated factors.
methodsWe conducted a single-center retrospective cohort study of consecutive adults undergoing primary OAGB or RYGB (January 2020-December 2022). Serum copper was measured preoperatively and at 6 months and 12 months. Copper deficiency was defined as serum copper < 75 µg/dL. Multivariable logistic regression assessed associations of age, sex, procedure type, and 6-month percent total weight loss (%TWL) with deficiency; receiver operating characteristic (ROC) analysis explored a 6-month %TWL threshold.
resultsAmong 294 patients (OAGB n = 107; RYGB n = 187; mean age 38.8 ± 9.9 years; 83% women), deficiency prevalence across 6, and 12 months did not differ between procedures. Mean serum copper declined from baseline to 6 months in both groups and remained below baseline at 12 months. In adjusted analyses, female sex and greater 6-month %TWL were independently associated with copper deficiency at 6 months; age and procedure type were not. ROC analysis suggested an exploratory 6-month %TWL threshold of ~ 29% for identifying higher-risk patients (AUC 0.64). No consistent between-group differences were observed in hematologic or iron indices by copper status.
conclusionCopper deficiency rates through 12 months were comparable after OAGB and RYGB; however, mean serum copper declined after both procedures. Greater early weight loss was associated with deficiency, supporting targeted biochemical surveillance-particularly within the first postoperative year-and reinforcement of supplementation adherence.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.